New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
08:59 EDTAKBA, WBMD, LXRX, FB, CVM, ICPT, MDT, C, NBG, ACOR, EW, YHOOOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Citigroup (C), up 3.7%. ALSO HIGHER: Yahoo (YHOO), up 1.7% after upgraded to Buy from Neutral at SunTrust... Facebook (FB), up 2.5% after Financial Times reports company looking to provide financial services... Lexicon (LXRX), up 19.5% after achieving positive results in Type 1 diabetes clinical trial... Akebia (AKBA), up 13.8% after initiated at Nomura, Credit Suisse, Morgan Stanley and UBS... WebMD (WBMD), up 10% after saying it now sees Q1 adjusted EBITDA to come in above the high end of its previous guidance... Intercept (ICPT), up 4.9% after reporting additional data from POISE trial at EASL... Ewards Lifesciences (EW), up 11.3% after a district court granted a preliminary injunction limiting the sale of Medtronic's (MDT) CoreValve system in the U.S. Medtronic shares down 5.2% following the news. ALSO LOWER: National Bank of Greece (NBG), down 10.7% after Reuters says bank selected Goldman Sachs (GS) and Morgan Stanley (MS) as global coordinators for a planned equity offering... : CEL-SCI (CVM), down 10.6% after announcing intent to offer common stock, six month warrants in 'best efforts' offering... Acorda Therapeutics (ACOR), down 6.2% after pushing off start of Phase 3 study of dalfampridine-QD to second half of year.
News For YHOO;C;FB;EW;MDT;LXRX;ACOR;ICPT;WBMD;NBG;CVM;AKBA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
November 11, 2014
12:02 EDTYHOOYahoo could create $19 in shareholder value, says Wolfe Research
Subscribe for More Information
12:00 EDTICPTIntercept results said to be rejected by New England Journal, Bloomberg says
Subscribe for More Information
10:44 EDTYHOOAlibaba Chairman Ma thinks Yahoo 'happy' with company performance
Alibaba (BABA) Chairman Jack Ma says his company must focus on itself, not on Yahoo (YHOO), but he believes Yahoo is happy with Alibaba's performance. Ma is speaking on CNBC.
10:27 EDTYHOOAlibaba sets Singles' Day record, analysts start coverage with upbeat notes
Chinese e-commerce giant Alibaba (BABA) generated record sales during the Chinese Singles Day holiday and a number of research firms initiated coverage of the stock with upbeat notes. WHAT'S NEW: Alibaba announced that a record $8B of products had been sold on its website with a few hours left in the Chinese Singles' Day holiday. Many Chinese citizens buy gifts on e-commerce websites during the holiday. During last year's festival, $5.7B of products were purchased on Alibaba's websites. ANALYST INITIATIONS: Oppenheimer analyst Ella Ji initiated coverage of Alibaba with an Outperform rating in a note to investors last night. Alibaba's ecosystem will make it difficult for competitors to challenge it for a long time, Ji believes. The ecosystem also boosts Alibaba's revenue growth and margins, according to the analyst. The e-commerce giant's strong brand, along with its large and loyal customer base, help make it one of the best-positioned companies in the Chinese Internet space, contended the analyst. He predicted that its revenue and profits will grow at a compound annual growth rate of 34% and 32%, respectively, from fiscal 2014 to fiscal 2019. The analyst set a $133 price target on the shares. HSBC earlier today initiated coverage of Alibaba with an Overweight rating. WHAT'S NOTABLE: Needham yesterday afternoon raised its price target for Yahoo (YHOO) shares to $55, citing higher than previously expected trading values for Alibaba. The firm believes Yahoo shares are pricing in negative 6% EBITDA growth for the company, which it views as too pessimistic. Needham, which expects positive EBITDA growth for Yahoo, kept a Buy rating on the stock. PRICE ACTION: In early trading, Alibaba fell 2.6% to $116 per share. However, the stock has risen nearly 18% in the last five days.
09:37 EDTCActive equity options trading
Subscribe for More Information
08:38 EDTYHOOYahoo price target raised to $55 from $48 at Needham (yesterday)
Needham yesterday afternoon raised its price target for Yahoo (YHOO) shares to $55 citing higher than previously expected trading values for Alibaba (BABA). The firm believes Yahoo shares are pricing in negative 6% EBITDA growth for the company, which it views as too pessimistic. Needham expects positive EBITDA growth for Yahoo and keeps a Buy rating on the stock.
07:24 EDTMDTMedtronic submits commitments to EU related to Covidien merger
Subscribe for More Information
07:14 EDTCJudge allows Citigroup to process next Argentina bond payout, Reuters reports
Subscribe for More Information
November 10, 2014
17:40 EDTYHOOYahoo could go higher, Barron's says
Subscribe for More Information
16:00 EDTYHOOOptions Update; November 10, 2014
Subscribe for More Information
12:53 EDTFBFacebook says has over 50M monthly active users for Messenger
Subscribe for More Information
11:39 EDTYHOOStocks with call strike movement; YHOO NEM
Subscribe for More Information
10:48 EDTFBFacebook enhances users' control over News Feeds
Facebook on Friday announced that News Feed settings will now show a list of the top people, Pages and Groups that users have seen in their News Feeds over the past week. Users can choose to sort by people, Pages or Groups posts, or see an overall summary., the social network said. They can unfollow any friend, Page or Group if they donít want to see their stories in their News Feeds, Facebook added. Users can also see who theyíve unfollowed in the past and can choose to re-follow them at anytime, the company stated. If users see a story they're not interested in or donít want to see, they can tap the arrow in the top right of that story to hide it, Facebook said. Reference Link
09:35 EDTFBActive equity options trading
Subscribe for More Information
09:10 EDTMDTMedtronic announces Japanese approval, launch of Evera MRI SureScan ICD
Subscribe for More Information
08:36 EDTICPTIntercept price target lowered to $125 from $172 at FBR Capital
FBR Capital lowered its price target for Intercept shares to $125 saying its talks with experts and cardiologists indicate the company's OCA drug is unlikely to be a "silver bullet" for the treatment of nonalcoholic steatohepatitis. FBR notes that while OCA appears to improve the liver, the drug worsens many of the other derangements like lipid and glucose homeostasis. FBR decreased the probability of success in NASH to 55% from 60%, and lowered its peak OCA sales estimate to $5.2B. It keeps an Underperform rating on Intercept shares.
07:03 EDTAKBAAkebia reports Q3 EPS (47c), two estimates (45c)
Subscribe for More Information
06:46 EDTCRegulators set new capital buffer rule for banks, Reuters reports
Global banks should have buffers of bonds or equity worth 16%-20% of their risk-weighted assets, beginning in January 2019, The Financial Stability Board decided, according to Reuters. The board said the buffer would prevent the need for government bailouts, the news service explained. Publicly traded global banks include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) Wells Fargo (WFC), Banco Santander (SAN), Barclays (BCS), Credit Suisse (CS), Deutsche Bank (DB), HSBC (HSBC), ING Groep (ING), Lloyds Banking (LYG), RBS (RBS) and UBS (UBS). Reference Link
06:37 EDTCSumitomo Mitsui in lead for Citigroup's Japan retail operations, WSJ reports
Subscribe for More Information
06:18 EDTCUBS to settle misconduct allegations at precious metals trading unit, FT reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use